Funding awarded
- "Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis" awarded by National Cancer Institute Principal Investigator 2023 - 2028
- Defining Evolutionary Trajectories Driving Prostate Cancer Metastases awarded by American Cancer Society Principal Investigator 2021 - 2026
- Determining and Targeting Evolutionary Trajectories Driving Bladder Cancer awarded by Starr Cancer Consortium Principal Investigator 2023 - 2025
- Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancer awarded by National Cancer Institute Co-Investigator 2025 - 2030
- Defining Evolution of Prostate Cancer Metastasis Under Therapeutic Pressure Using Recordable Barcode awarded by Prostate Cancer Foundation Key Personnel 2025 - 2028
- Determining Metastatic Drivers of Pten/p53-Loss-Driven Prostate Cancer Using Evolving DNA Barcodes awarded by United States Department of Defense Key Personnel 2022 - 2025